Rare Laryngeal Cancer Driven by BRD4::NUTM1 Fusion Resists Every Therapy in Four-Year Case
A detailed case report documents a 30-year-old man with BRD4::NUTM1 fusion laryngeal NUT carcinoma who survived four years while every ...
Tag: BET inhibitor
Nanoparticles That Clear Scar-Driving Immune Cells Open Tumors to Immunotherapy
Memorial Sloan Kettering scientists engineered fucoidan-coated nanoparticles that selectively eliminate senescent, P-selectin-positive macrophages driving fibrosis, dissolving scar barriers around tumors ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!